Review began 02/22/2023 review ended 03/06/2023 published 03/08/2023 © copyright

HIGHLIGHTS

• who: Report and collaborators from the Department of Propaedeutics of Internal Diseases, University Hospital Alexandrovska, Medical have published the research: Review began 02/22/2023 Review ended 03/06/2023 Published 03/08/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/08,/2023
• what: The authors and others think that the findings of AGREE trial may be among the main reasons why all clinical studies testing the therapeutic role of colchicine for COVID-19 patients used low doses, even though AGREE trial itself was designed to test the efficacy of colchicine in acute gout . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.